thejapantimes, 3 months ago to business Japan's Takeda Pharmaceutical is holding talks with Indian regulators to make its dengue vaccine available in the country. https://www.japantimes.co.jp/business/2024/02/28/companies/takeda-dengue-vaccine-india/ #business #companies #takedapharmaceutical #pharmaceuticals #india #health #vaccinations #denguefever
Japan's Takeda Pharmaceutical is holding talks with Indian regulators to make its dengue vaccine available in the country. https://www.japantimes.co.jp/business/2024/02/28/companies/takeda-dengue-vaccine-india/ #business #companies #takedapharmaceutical #pharmaceuticals #india #health #vaccinations #denguefever
thejapantimes, 8 months ago to Japan A Japanese-led research team has said it has identified how infections with the coronavirus can cause inflammation in blood vessels and blood clots, resulting in severe COVID-19 cases. https://www.japantimes.co.jp/news/2023/10/07/japan/science-health/covid-severe-cases-research/?utm_content=bufferb8807&utm_medium=social&utm_source=mastodon&utm_campaign=bffmstdn #japan #sciencehealth #osakauniversity #tokyomedicalanddentaluniversity #takedapharmaceutical #medicine #health #covid19 #covid19injapan
A Japanese-led research team has said it has identified how infections with the coronavirus can cause inflammation in blood vessels and blood clots, resulting in severe COVID-19 cases. https://www.japantimes.co.jp/news/2023/10/07/japan/science-health/covid-severe-cases-research/?utm_content=bufferb8807&utm_medium=social&utm_source=mastodon&utm_campaign=bffmstdn #japan #sciencehealth #osakauniversity #tokyomedicalanddentaluniversity #takedapharmaceutical #medicine #health #covid19 #covid19injapan